Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine

被引：0
|
作者：
Yoshinori Ito
Yohei Osaki
Nahomi Tokudome
Tsutomu Sugihara
Shunji Takahashi
Takuji Iwase
Kiyohiko Hatake
机构：
[1] The Cancer Institute of Japanese Foundation for Cancer Research,Department of Medical Oncology
[2] Cancer Institute Hospital,Department of Breast Oncology
[3] Japanese Foundation for Cancer Research,undefined
来源：
Breast Cancer | 2009年 / 16卷
关键词：
S-1; Capecitabine; Taxane; Anthracycline; Metastatic breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 131
页数：5
相关论文
共 50 条
  • [1] Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine
    Ito, Yoshinori
    Osaki, Yohei
    Tokudome, Nahomi
    Sugihara, Tsutomu
    Takahashi, Shunji
    Iwase, Takuji
    Hatake, Kiyohiko
    BREAST CANCER, 2009, 16 (02) : 126 - 131
  • [2] Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer
    Osako, Tomo
    Ito, Yoshinori
    Ushijima, Masaru
    Takahashi, Shunji
    Tokudome, Nahomi
    Sugihara, Tsutomu
    Iwase, Takuji
    Matsuura, Masaaki
    Hatake, Kiyohiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) : 865 - 871
  • [3] Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer
    Tomo Osako
    Yoshinori Ito
    Masaru Ushijima
    Shunji Takahashi
    Nahomi Tokudome
    Tsutomu Sugihara
    Takuji Iwase
    Masaaki Matsuura
    Kiyohiko Hatake
    Cancer Chemotherapy and Pharmacology, 2009, 63
  • [4] Clinical efficacy of S-1 in pretreated metastatic breast cancer patients
    Shien, Tadahiko
    Shimizu, Chikako
    Akashi-Tanaka, Sadako
    Yonemori, Kan
    Kohno, Tsutomu
    Hojo, Takashi
    Ando, Masashi
    Katsumata, Noriyuki
    Kinoshita, Takayuki
    Fujiwara, Yasuhiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (03) : 172 - 175
  • [5] Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Altorjai, Gabriela
    Pluschnig, Ursula
    Rudas, Margaretha
    Mader, Robert M.
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3853 - 3858
  • [6] Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer
    Sarici, Furkan
    Aksoy, Serean
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (02): : 85 - 91
  • [7] Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
    Fedele, P.
    Marino, A.
    Orlando, L.
    Schiavone, P.
    Nacci, A.
    Sponziello, F.
    Rizzo, P.
    Calvani, N.
    Mazzoni, E.
    Cinefra, M.
    Cinieri, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (01) : 24 - 29
  • [8] SAFETY AND EFFICACY OF LOW DOSE METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Fedele, P.
    Orlando, L.
    Schiavone, P.
    Rizzo, P.
    Calvani, N.
    Marino, A.
    D'Amico, M.
    Sponziello, F.
    Nacci, A.
    Mazzoni, E.
    Chetri, M. C.
    Cinefra, M.
    Cinieri, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S100 - S100
  • [9] Metronomic capecitabine in heavily pretreated metastatic triple negative breast cancer
    El-Sadda, W. M.
    CANCER RESEARCH, 2017, 77
  • [10] Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Osako, Tomo
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Iwase, Takuji
    Hatake, Kiyohiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 159 - 164
12345